BlackRock Fund Advisors - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$27,898,000
-29.4%
6,837,786
+9.8%
0.01%
-37.5%
Q3 2016$39,540,000
+30.2%
6,226,723
+10.5%
0.01%
+14.3%
Q2 2016$30,376,000
-31.3%
5,635,702
+6.7%
0.01%
-30.0%
Q1 2016$44,222,000
+6.4%
5,283,448
+0.4%
0.01%0.0%
Q4 2015$41,567,000
-6.5%
5,261,702
+0.8%
0.01%
-16.7%
Q3 2015$44,437,000
-31.4%
5,221,783
-0.3%
0.01%
-25.0%
Q2 2015$64,742,000
+9.4%
5,235,904
+5.1%
0.02%
+14.3%
Q1 2015$59,175,000
+10.3%
4,981,073
+5.0%
0.01%
+7.7%
Q4 2014$53,626,000
+40.7%
4,745,667
+9.3%
0.01%
+18.2%
Q3 2014$38,117,000
+24.4%
4,341,343
+3.3%
0.01%
+22.2%
Q2 2014$30,645,000
+66.2%
4,203,723
+14.9%
0.01%
+80.0%
Q1 2014$18,441,000
-2.4%
3,658,982
+3.2%
0.01%
-16.7%
Q4 2013$18,895,000
+38.2%
3,544,276
-1.8%
0.01%
+20.0%
Q3 2013$13,674,000
-31.1%
3,607,884
+22.5%
0.01%
-28.6%
Q2 2013$19,857,0002,946,1660.01%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,100,140$25,968,0006.81%
Portolan Capital Management 664,298$8,214,0001.15%
GARRISON BRADFORD & ASSOCIATES INC 90,700$1,122,0001.10%
Opus Point Partners Management, LLC 72,009$890,0000.70%
Eagle Ridge Investment Management 122,500$1,515,0000.68%
EAM Investors, LLC 350,410$4,333,0000.51%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,881,667$60,362,0000.37%
Cannell & Co. 1,051,178$12,998,0000.37%
Birchview Capital, LP 42,300$523,0000.28%
Tekla Capital Management LLC 567,787$7,021,0000.25%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders